Glioblastoma multiforme(GBM): Does the addition of intratumoral chemotherapy improve survival patients treated with aggressive surgical resection and irradiation?

被引：0
|
作者：
Amendola, BE
Wolf, AL
Coy, SR
Amendola, MA
Bloch, L
机构：
来源：
RADIOLOGY | 2002年 / 225卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [41] Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy
    Cheun, Jong-Ho
    Lee, Young Joo
    Lee, Jun-Hee
    Shin, Yungil
    Chun, Jung Whan
    Baek, Soo Yeon
    Kim, Hong-Kyu
    Lee, Han-Byoel
    Yu, Jonghan
    Chae, Byung Joo
    Han, Wonshik
    Lee, Jeong Eon
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 683 - 692
  • [42] Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy
    Jong-Ho Cheun
    Young Joo Lee
    Jun-Hee Lee
    Yungil Shin
    Jung Whan Chun
    Soo Yeon Baek
    Hong-Kyu Kim
    Han-Byoel Lee
    Jonghan Yu
    Byung Joo Chae
    Wonshik Han
    Jeong Eon Lee
    Breast Cancer Research and Treatment, 2022, 194 : 683 - 692
  • [43] Addition of etoposide to cyclophosphamide and total body irradiation as a conditioning regimen for allogeneic bone marrow transplantation does not improve disease free survival in patients with hematologic malignancies.
    Richart, JM
    McIntyre, W
    Klebert, K
    Petruska, P
    Adkins, D
    Dunphy, F
    Pincus, S
    BLOOD, 1997, 90 (10) : 4510 - 4510
  • [44] A Phase 2 Multicenter Trial of Autologous Heat Shock Protein-Peptide Vaccine (HSPPC-96) for Recurrent Glioblastoma Multiforme (GBM) Patients Shows Improved Survival Compared to a Contemporary Cohort Controlled for Age, KPS and Extent of Resection
    Parsa, Andrew Thomas
    Crane, Courtney
    Han, Seunggu J.
    Kivett, Valerie
    Fedoroff, Anne
    Butowski, Nicholas
    Chang, Susan
    Prados, Michael
    Clarke, Jennifer
    Berger, Mitchel S.
    McDermott, Michael W.
    Aghi, Manish K.
    Sloan, Andrew E.
    Bruce, Jeffrey N.
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A406 - A406
  • [45] Impact of Human Equilibrative Nucleoside Transporter 1 Expression on Long Term Survival of Pancreatic Cancer Patients Treated with Gemcitabine Based Adjuvant Chemotherapy After Surgical Resection
    Kondo, N.
    Murakami, Y.
    Uemura, K.
    Sudo, T.
    Hashimoto, Y.
    Nakagawa, N.
    Sueda, T.
    PANCREAS, 2012, 41 (07) : 1149 - 1150
  • [46] Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide
    Papaldo, P
    Lopez, M
    Cortesi, E
    Cammilluzzi, E
    Antimi, M
    Terzoli, E
    Lepidini, G
    Vici, P
    Barone, C
    Ferretti, G
    Di Cosimo, S
    Nistic, C
    Carlini, P
    Conti, F
    Di Laura, L
    Botti, C
    Vitucci, C
    Fabi, A
    Giannarelli, D
    Marolla, P
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) : 3462 - 3468
  • [47] RESPONSE TO DRS SIMPSON, ET-AL - INFLUENCE OF LOCATION AND EXTENT OF SURGICAL RESECTION ON SURVIVAL OF PATIENTS WITH GLIOBLASTOMA-MULTIFORME - RESULTS OF 3 CONSECUTIVE RADIATION-THERAPY ONCOLOGY GROUP CLINICAL-TRIALS
    WARNKE, PC
    KRETH, FW
    SCHEREMET, R
    OSTERTAG, CB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01): : 220 - 220
  • [48] Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)
    Malmstrom, A.
    Gronberg, B. H.
    Stupp, R.
    Marosi, C.
    Frappaz, D.
    Schultz, H. P.
    Abacioglu, M. U.
    Kinhult, S.
    Henriksson, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [49] Plasma proteomic markers prognostic or predictive for survival of patients with newly diagnosed glioblastoma who were treated in a phase II trial with standard care and the addition of the novel patient-specific dendritic cell vaccine AV-GBM-1
    Bota, Daniela A.
    Piccioni, David E.
    Duma, Christopher M.
    LaRoca, Renato V.
    Kesari, Santosh
    Abedi, Mehrdad
    Aiken, Robert D.
    Poole, Aleksandra J.
    Nistor, Gabriel I.
    Dillman, Robert O.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] Combined Analysis of Dihydropyrimidine Dehydrogenase and Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Carcinoma Patients Treated with Adjuvant Gemcitabine Plus S-1 Chemotherapy after Surgical Resection
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Sueda, Taijiro
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S646 - S655
12345